Where does the money go to? Cost analysis of gynecological patients with a benign condition

Show simple item record

dc.contributor.author Pynnä, Kristiina
dc.contributor.author Räsänen, Pirjo
dc.contributor.author Roine, Risto P.
dc.contributor.author Vuorela, Piia
dc.contributor.author Sintonen, Harri
dc.date.accessioned 2021-09-13T10:43:01Z
dc.date.available 2021-09-13T10:43:01Z
dc.date.issued 2021-07-09
dc.identifier.citation Pynnä , K , Räsänen , P , Roine , R P , Vuorela , P & Sintonen , H 2021 , ' Where does the money go to? Cost analysis of gynecological patients with a benign condition ' , PLoS One , vol. 16 , no. 7 , 0254124 . https://doi.org/10.1371/journal.pone.0254124
dc.identifier.other PURE: 168422028
dc.identifier.other PURE UUID: e1505804-fe33-404a-8983-c245f0674294
dc.identifier.other WOS: 000674301400092
dc.identifier.uri http://hdl.handle.net/10138/334313
dc.description.abstract Objectives The impact of benign gynecological conditions on life of women and on costs for the society is high. The purpose of this study is to gain knowledge and understanding of costs of the treatment of these disorders in order to be able to improve the clinical care processes, gain insight into feasible savings opportunities and to allocate funds wisely. Methods The healthcare processes of 311 women attending university or community hospitals in the Helsinki and Uusimaa Hospital District between June 2012 and August 2013 due to a benign gynecological condition were followed up for two years and treatment costs analysed. Results Total direct hospital costs averaged 689euro at six months and 2194euro at two years. The most expensive treatment was that of uterine fibroids in the short term and that of endometriosis and fibroids later on. Costs did not depend on hospital size. Surgical operations caused nearly half of hospital costs. Productivity loss caused biggest expenses outside of the hospital. LNG-IUD (levonorgestrel-releasing intrauterine device) accounted for the largest pharmaceutical costs for patients. Hospital treatment was associated with a reduced need for outpatient services during follow-up. Conclusions A majority of direct hospital costs arise over time. This stresses the need for prolonged healthcare management. To control costs, the need for repetitive doctors' appointments, monitoring tests, and ward treatments should be carefully evaluated. Procedures not needing an operation theatre (for example hysteroscopy for polypectomy), should be done ambulatorily. en
dc.format.extent 11
dc.language.iso eng
dc.relation.ispartof PLoS One
dc.rights cc_by
dc.rights.uri info:eu-repo/semantics/openAccess
dc.subject QUALITY-OF-LIFE
dc.subject WOMEN
dc.subject OUTPATIENT
dc.subject 3123 Gynaecology and paediatrics
dc.title Where does the money go to? Cost analysis of gynecological patients with a benign condition en
dc.type Article
dc.contributor.organization HUS Gynecology and Obstetrics
dc.contributor.organization Department of Obstetrics and Gynecology
dc.contributor.organization University of Helsinki
dc.contributor.organization Helsinki University Hospital Area
dc.contributor.organization HUS Helsinki and Uusimaa Hospital District
dc.contributor.organization Clinicum
dc.contributor.organization Harri Sintonen Research Group
dc.contributor.organization Department of Public Health
dc.description.reviewstatus Peer reviewed
dc.relation.doi https://doi.org/10.1371/journal.pone.0254124
dc.relation.issn 1932-6203
dc.rights.accesslevel openAccess
dc.type.version publishedVersion

Files in this item

Total number of downloads: Loading...

Files Size Format View
journal.pone.0254124.pdf 893.0Kb PDF View/Open

This item appears in the following Collection(s)

Show simple item record